You are here: Home Newsroom Features Marc Donovan, Boots Chief Pharmacist joins FIP Congress 2018

Marc Donovan, Boots Chief Pharmacist joins FIP Congress 2018

06 September 2018
Feature Healthcare

This September, Boots has joined the FIP World Congress of Pharmacy and Pharmaceutical Sciences. With over 3,000 delegates who travelled to Glasgow to attend, the congress is one of the biggest gathering of pharmacists internationally, and it’s one of the key pharmacy events of the year.

The theme this year is Pharmacy: Transforming outcomes; bringing together pharmacy practitioners and pharmaceutical scientists from around the world to consider ways of extending the role of pharmacists so that they play a full part in ensuring patients, and health systems, achieve full benefit from the medicines people take.

Marc Donovan, Chief Pharmacist for Boots joined the speaker programme to highlight the changing role of community pharmacies and how we can work together to improve patient safety and add value. He said: “Healthcare needs in the UK are changing. With demographic shifts and increasing use of technology and self-care, there are more people being treated in primary care; but with fewer GPs and increasing pressure on the NHS, the role of pharmacy is evolving to support changing patient needs and NHS demands. We believe that pharmacy, working in collaboration with policy makers, healthcare providers and academics, can add more value to patients and healthcare systems, and that pharmacists have a role to play in working with GPs in new models of care.”

Boots also had three academic papers that were presented in the poster exhibition at the conference: “Point prevalence audit of care home residents and carers across the UK in the appropriate use of antibiotics”, “Antibiotic consumption in care homes across the United Kingdom; baseline data”, and “Role of a Research Governance framework as an enabler to community pharmacy practice based research”.

In its 78th year, this is the first time that the FIP World Congress has been held in the UK for nearly 40 years, making it a truly unique learning opportunity for pharmacists and pharmaceutical scientists in the UK. Each year, it moves to a new country, where it puts a spotlight on how pharmacy works in that market. Last year, it was held in Seoul, South Korea.

News

What’s new at Boots? Find out the latest updates from the UK’s largest pharmacy-led health and beauty chain – from new products and services to important business developments.

xx

Experts

Read the views of our team members at Boots, who are experts in their field. Find out what they think about the most important issues of the day – from healthcare equality to sustainability.

xx

Media Resources

A you are a journalist looking for information and resources about Boot? Visit our media resources hub to access images, reports, spokespeople and videos.

xx

Boots is the UK’s leading health and beauty retailer with over 52,000 team members and 2,100 stores, ranging from local community pharmacies to large destination health and beauty stores.*

Boots serves its customers and patients for life as the leading provider of healthcare on the high street and the UK’s number one beauty destination. It offers an unrivalled depth and breadth of products, which incorporates its extensive own brand range and innovative portfolio of brands, including No7, the UK’s No1 skincare brand, Soap & Glory, Liz Earle Beauty and Sleek MakeUP.

2024 marks Boots’ 175th anniversary year. Founder John Boot opened a herbalist store in Nottingham in 1849 to offer an affordable alternative to traditional medicines. His son Jesse expanded the business to become a modern retailer and the biggest chemist in Britain. Throughout its history, Boots has listened, learned and innovated, and it continues to challenge itself to improve its products and services every day.

Boots is part of Walgreens Boots Alliance, which is a global leader in pharmacy-led, health and wellbeing retail.  More company information is available on boots-uk.com.

*Figures accurate as of 30 November 2023